No Detail Found!

Detection of Bacterial DNA in the Plasma of Psoriasis Patients and its Association with Serum Intestinal Fatty Acid Binding Protein Concentration

Author(s)
SAMAH ALI ABD Biotect. Dept., Coll. of Sci., Univ. of Baghdad, Iraq
JINAN MJ ALSAFFAR Ministry of Industry, Ibn Sina Research Center,Iraq
ALICE K. AGOP Biotect. Dept., Coll. of Sci., Univ. of Baghdad, Iraq
ENTISSAR JAWAD KADHEM Ministry of Industry, Ibn Sina Research Center,iraq
Abstract
Background: There is evidence of the role of microorganisms, in particular in the throat and skin in psoriasis pathogenesis. This study aimed to investigate the presence of bacterial DNA (bacDNA) in patients' plasma and its association with gut barrier integrity . Methodology: Plasma was collected from 60 psoriasis patients in the flare up stage and 40 healthy controls. BacDNA was detected by PCR amplification using a 16S ribosomal DNA primer. The amplified DNA fragments were then sequenced to determine their bacterial origin. Results: Bacterial DNA was detected in 51 of 60 patients and only in 4 of 40 healthy controls. BacDNA sequencing results revealed that these bacterial species originated from the gut and skin. On the other hand, intestinal fatty acid binding protein (IFABP) was measured by ELISA technique to investigate the integrity of the intestinal barrier. Serum concentrations of I-FABP were significantly higher in psoriasis patients compared with the healthy group and were positively correlated with the presence of bacDNA in patients' plasma. Conclusion: These findings suggest that psoriasis flare up is associated with translocation of bacteria and its metabolites into the blood stream, causing an immune system response. The specific mechanism of bacDNA in the pathogenesis of psoriasis needs to be comprehensively studied.
Publication Details
Page(s) 610-612
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 06, Year: 2022

Request the full text from PASTIC

Keywords
Psoriasis, Psoriasis, Psoriasis, skin-gut axes, gut barrier, I-FABP
References
Michalek IM,Loring B .2016 .. John SM. Global report on psoriasis. World Health Organization;, : .
De Vlam K,Gottlieb AB,Mease PJ . .Current concepts in psoriatic arthritis: pathogenesis and management. Acta dermato-venereologica. 2014 Nov, 1(6) : .
De Hertogh G,Aerssens J,Geboes KP,Geboes K. . .Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease. World journal of gastroenterology: WJG. 2008 Feb, 14(6) : 845.
Pelsers MM,Namiot Z,Kisielewski W,Namiot A,Januszkiewicz M,Hermens WT,Glatz JF . .Tissue distribution and clinical utility. 2003 Oct, 1(7) : 529-35.
Adriaanse MP,Tack GJ,Passos VL,Damoiseaux JG,Schreurs MW,Van Wijck K,Riedl RG,Masclee AA,Buurman WA,Mulder CJ,Vreugdenhil AC . .Serum IFABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Alimentary pharmacology & therapeutics, 37(4) : 482-90.
Vreugdenhil AC,Wolters VM,Adriaanse MP,Van den Neucker AM,van Bijnen AA,Houwen R,Buurman WA . .Additional value of serum I-FABP levels for evaluating celiac disease activity in children. 2011 Dec, 1(12) : 1435-41.
Thuijls G,Derikx JP,van Wijck K,Zimmermann LJ,Degraeuwe PL,Mulder TL,Van der Zee DC,Brouwers HA,Verhoeven BH,van Heurn LE,Kramer BW . .Noninvasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. 2010 Jun, 1(6) : 1174-80.
PASI Score Calculator . .. , : .
.2010 .Evidence for the presence of bacteria in the blood of psoriasis patients. Archives of dermatological research, 302(7) : 495-498.
Okubo Y,Oki N,Takeda H,Amaya M,Ito S,Osada M,Utsumi M,Koga M,Kawashima H M . .Increased microorganisms DNA levels in peripheral blood monocytes from psoriatic patients using PCR with universal ribosomal RNA primers. The Journal of Dermatology, 29(9) : 547-55.
Ramírez-Boscá A,Navarro-López V,Martínez-Andrés A,Such J,Francés R,de la Parte JH,Asín-Llorca M . .Identification of bacterial DNA in the peripheral blood of patients with active psoriasis. 2015 Jun, 1(6) : 670-1.
Sikora M,Chrabąszcz M,Maciejewski C,Zaremba M,Waśkiel A,Olszewska M,Rudnicka L M . .Intestinal barrier integrity in patients with plaque psoriasis. The Journal of dermatology, 45(12) : 1468-70.
Wells JM,Brummer RJ,Derrien M,MacDonald TT,Troost F,Cani PD,Theodorou V,Dekker J,Méheust A,De Vos WM,Mercenier A . .Homeostasis of the gut barrier and potential biomarkers. 2017 Mar, 1(3) : G171-93.
Gajda AM,Storch J . .Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine. 2015 Feb, 1(93) : 9-16.
Salim SY,Young PY,Churchill TA,Khadaroo RG . .Urine intestinal fatty acidbinding protein predicts acute mesenteric ischemia in patients. 2017 Mar, 1 : 258-65.
Coufal S,Kokesova A,Tlaskalova-Hogenova H,Frybova B,Snajdauf J,Rygl M,Kverka M. Urinary I-FABP,L-FABP I-FABP . .TFF-3, and SAA can diagnose and predict the disease course in necrotizing enterocolitis at the early stage of disease. , : .
.2020 .. 2020 Mar, 3 : .
Kittaka H,Akimoto H,Takeshita H,Funaoka H,Hazui H,Okamoto M,Kobata H,Ohishi Y. . .Usefulness of intestinal fatty acid-binding protein in predicting strangulated small bowel obstruction. 2014 Jun, 13(6) : e99915.
Oldenburger IB,Wolters VM,Kardol‐Hoefnagel T,Houwen RH,Otten HG . .Serum intestinal fatty acid-binding protein in the noninvasive diagnosis of celiac disease. Apmis, 126(3) : 186-90.
Sarikaya M,Ergül B,Doğan Z,Filik L,Can M,Arslan L M . .Intestinal fatty acid binding protein (I-FABP) as a promising test for Crohn's disease: a preliminary study. 2015 Jan, 1(1-2) : 87-91.
Yan D,Issa N,Afifi L,Jeon C,Chang HW,Liao W. . .The role of the skin and gut microbiome in psoriatic disease. 2017 Jun;6, (2) : 94-103.
Mattozzi C,Richetta AG,Cantisani C,Macaluso L,Calvieri S. . .Psoriasis: new insight about pathogenesis, role of barrier organ integrity, NLR/CATERPILLER family genes and microbial flora. The Journal of dermatology, 39(9) : 752-60.
Drago F,Ciccarese G,Indemini E,Savarino V,Parodi A . .Psoriasis and small intestine bacterial overgrowth. International journal of dermatology, 57(1) : 112-3.
Tan L,Zhao S,Zhu W,Wu L,Li J,Shen M,Lei L,Chen X,Peng C. . .The Akkermansia muciniphila is a gut microbiota signature in psoriasis. 2018 Feb;27, (2) : 144-9.
Parada Venegas D,De la Fuente MK,Landskron G,González MJ,Quera R,Dijkstra G,Harmsen HJ,Faber KN,Hermoso MA .2019 .Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. , 277 : .
. .. 2018 Feb, 28(1) : 1-7.
0

Citations

0

Downloads

66

Views